Pneumococcal vaccination coverage data by age group

Data by age group

9 months

"2-dose" vaccination coverage at 9 months of age with the pneumococcal conjugate vaccine, France, 2010–2015 (source: Drees, Data reported by maternal and child health services – 9-month health certificates. Processed by Santé publique France)

Year of data collection

2010

2011

2012

2013

2014

2015

2 doses at 9 months

91.2%

91.7%

92.6%

92.9%

93.6%

92.4%

24 months

Vaccination coverage ("at least 3 doses") at 24 months of age with the pneumococcal conjugate vaccine, France, 2010–2022 (source: Drees, Data from maternal and child health services – 24-month health certificates. Processed by Santé publique France)
Year of data collection 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022
3 doses by 24 months 88.6% 88.8% 88.8% 89.2% 89.3% 91.4% 91.8% 92.2% 92.4 93.1 95.0 94.7 95.7

6 years

Vaccination coverage for at least 3 doses: 83.3% [82.8–83.8] (source: Survey of children in the final year of preschool (ages 5–6), France, Drees-Dgesco, 2012–2013 National Health Survey, processed by InVS)

In adults

Coverage among older adults, 2011.Among people aged 65 or older with an underlying chronic condition, 8.1% (95% CI: 5.2–12.4) had received the pneumococcal vaccine (23-valent polysaccharide vaccine) within the past 5 years, and 8.3% (95% CI: 5.4–12.7) for 5 years or more. These proportions were 4.8% (3.3–6.9) and 5.7% (4.1–7.8), respectively, among people aged 65 or older in good health. (source: Guthmann JP. National Vaccination Coverage Survey, France, January 2011. Seasonal influenza vaccination coverage in target groups and measurement of vaccine efficacy. Vaccination coverage with diphtheria-tetanus-polio (dTP) and pneumococcal vaccines among people aged 65 and older. Saint-Maurice: Institute for Public Health Surveillance, 2011. 21 p).